Fisher & Paykel Healthcare Corporation Ltd
NZX:FPH

Watchlist Manager
Fisher & Paykel Healthcare Corporation Ltd Logo
Fisher & Paykel Healthcare Corporation Ltd
NZX:FPH
Watchlist
Price: 38.34 NZD 1.51% Market Closed
Market Cap: 22.5B NZD
Have any thoughts about
Fisher & Paykel Healthcare Corporation Ltd?
Write Note
Section:
 

Relative Value

The Relative Value of one FPH stock under the Base Case scenario is 36.03 NZD. Compared to the current market price of 38.34 NZD, Fisher & Paykel Healthcare Corporation Ltd is Overvalued by 6%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

FPH Relative Value
Base Case
36.03 NZD
Overvaluation 6%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

11.9
P/S
P/S
Price to Sales
11.9
vs History
15
vs Industry
13
Median 3Y
8.9
Median 5Y
9.5
Industry
2.3
Forward
11.1
More Details
125.9
P/E
P/E
Price to Earnings
125.9
vs History
6
vs Industry
3
Median 3Y
53.1
Median 5Y
52.1
Industry
23.1
Forward
61.4
More Details
44.4
P/OCF
P/OCF
Price to OCF
44.4
vs History
39
vs Industry
8
Median 3Y
40.5
Median 5Y
42.7
Industry
14.2
More Details
105.3
P/FCFE
P/FCFE
Price to FCFE
105.3
vs History
44
vs Industry
3
Median 3Y
103
Median 5Y
96.2
Industry
20.1
More Details
11.6
P/B
P/B
Price to Book Value
11.6
vs History
33
vs Industry
6
Median 3Y
8.8
Median 5Y
10.9
Industry
2.2
More Details
11.9
EV/S
EV/S
Enterprise Value to Sales
11.9
vs History
15
vs Industry
12
Median 3Y
8.9
Median 5Y
9.4
Industry
2.4
Forward
11.1
More Details
19.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
19.5
vs History
9
vs Industry
11
Median 3Y
14.6
Median 5Y
15.2
Industry
5
More Details
69.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
69.9
vs History
0
vs Industry
5
Median 3Y
39.7
Median 5Y
38.9
Industry
12.7
Forward
36.3
More Details
69.9
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
69.9
vs History
0
vs Industry
6
Median 3Y
39.7
Median 5Y
38.9
Industry
17.1
Forward
45.3
More Details
44.3
EV/OCF
EV/OCF
Enterprise Value to OCF
44.3
vs History
41
vs Industry
8
Median 3Y
40.4
Median 5Y
42.1
Industry
14
More Details
57.9
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
57.9
vs History
65
vs Industry
2
Median 3Y
79.2
Median 5Y
79.2
Industry
18
More Details
10.7
EV/IC
EV/IC
Enterprise Value to IC
10.7
vs History
38
vs Industry
9
Median 3Y
7.7
Median 5Y
10.1
Industry
1.9
More Details

Multiples Across Competitors

FPH Competitors Multiples
Fisher & Paykel Healthcare Corporation Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
NZ
Fisher & Paykel Healthcare Corporation Ltd
NZX:FPH
22.5B NZD 11.9 125.9 69.9 69.9
US
Abbott Laboratories
NYSE:ABT
199B USD 4.8 34.5 20 29.3
US
Intuitive Surgical Inc
NASDAQ:ISRG
191.3B USD 24.3 85.3 72.8 90.4
US
Stryker Corp
NYSE:SYK
141.3B USD 6.4 39.4 25.6 31
US
Boston Scientific Corp
NYSE:BSX
134.2B USD 8.4 74.8 34.3 49
IE
Medtronic PLC
NYSE:MDT
104.6B USD 3.2 24.4 13.6 19.3
US
Becton Dickinson and Co
NYSE:BDX
65.6B USD 3.3 38 15.7 28.2
DE
Siemens Healthineers AG
XETRA:SHL
58.1B EUR 2.6 31.2 17.7 25.8
US
Edwards Lifesciences Corp
NYSE:EW
44.5B USD 7.9 10.7 23.8 26.1
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
311.1B CNY 8.4 25.1 21.8 21.8
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
36.3B USD 1.9 21.6 13.6 16.7

See Also

Summary
FPH intrinsic value, competitors valuation, and company profile.
DCF Valuation
FPH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
FPH stock valuation using valuation multiples.
Wall Street Estimates
FPH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
FPH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.